Clare Aubrey Medendorp

Clare Aubrey Medendorp has extensive work experience in the pharmaceutical industry. Clare began their career at Merck in 2009 as a Senior Research Chemist, where they worked until 2011. Clare then joined Millennium Pharmaceuticals as a Senior Scientist in 2012 and remained in that role until 2016. Following that, they worked at TESARO, Inc. as an Associate Director from 2016 to 2018. Clare then joined Blueprint Medicines in 2018, starting as a Principal Scientist and eventually becoming a Senior Principal Scientist in 2021. In 2022, they joined Tremeau Pharmaceuticals, Inc. as a Director until 2023. Currently, Clare is the Sr. Director at IDRx since 2023.

Clare Aubrey Medendorp holds a Ph.D. in Pharmaceutical Sciences from the University of Kentucky, which they obtained between the years 2003 and 2011. Prior to that, they completed their undergraduate studies at the University of Tennessee, Knoxville, where they earned a B.S. in Biomedical Engineering from 1998 to 2002.